Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Karlícek

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Vnitrni Lekarstvi|July 1, 1988
[The risk profile of patients with myocardial infarct at a young age]O Topolcan, V Karlícek
Casopis Lekaru Ceskych|February 13, 1976
[Long-term follow-up of secretion of immunoreactive insulin in post-myocardial infarction patients (author's transl)]V Karlícek, O Topolcan
Casopis Lekaru Ceskych|January 11, 1974
[Cadmium in kidneys of patients with essential hypertension and renal hypertension (author's transl)]V Karlícek, O Topolcan
Casopis Lekaru Ceskych|April 1, 1976
[Immunoreactive insulin in acute infarction of the myocardium (author's transl)]V Karlícek, O Topolcan
Casopis Lekaru Ceskych|September 30, 1988
[Theoretical basics of prevention in clinical practice]V Karlícek, J Simon
Casopis Lekaru Ceskych|February 20, 1976
[Immunoreactive insulin in obese patients with coronary atherosclerosis and myocardial infarct (author's transl)]V Karlícek, O Topolcan, Z Chudácek
Casopis Lekaru Ceskych|December 6, 1985
[Immunoreactive insulin and comprehensive spa therapy]L Spisák, V Karlícek, O Topolcan
Casopis Lekaru Ceskych|June 22, 1984
[Immunoreactive insulin and its incidence in myocardial infarct and cerebrovascular accidents]V Karlícek, O Topolcan, J Simon
Casopis Lekaru Ceskych|March 19, 1976
[Plasmatic immunoreactive insulin in trained athletes]V Karlícek, O Topolcan, J Jeschke
Casopis Lekaru Ceskych|June 16, 1978
[Contemporary state and perspectives of radioimmunological methods in nephrology (author's transl)]K Horký, K Opatrný, V Karlícek, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Vnitrni Lekarstvi|July 1, 1988
[The risk profile of patients with myocardial infarct at a young age]O Topolcan, V Karlícek
Casopis Lekaru Ceskych|February 13, 1976
[Long-term follow-up of secretion of immunoreactive insulin in post-myocardial infarction patients (author's transl)]V Karlícek, O Topolcan
Casopis Lekaru Ceskych|January 11, 1974
[Cadmium in kidneys of patients with essential hypertension and renal hypertension (author's transl)]V Karlícek, O Topolcan
Casopis Lekaru Ceskych|April 1, 1976
[Immunoreactive insulin in acute infarction of the myocardium (author's transl)]V Karlícek, O Topolcan
Casopis Lekaru Ceskych|September 30, 1988
[Theoretical basics of prevention in clinical practice]V Karlícek, J Simon
Casopis Lekaru Ceskych|February 20, 1976
[Immunoreactive insulin in obese patients with coronary atherosclerosis and myocardial infarct (author's transl)]V Karlícek, O Topolcan, Z Chudácek
Casopis Lekaru Ceskych|December 6, 1985
[Immunoreactive insulin and comprehensive spa therapy]L Spisák, V Karlícek, O Topolcan
Casopis Lekaru Ceskych|June 22, 1984
[Immunoreactive insulin and its incidence in myocardial infarct and cerebrovascular accidents]V Karlícek, O Topolcan, J Simon
Casopis Lekaru Ceskych|March 19, 1976
[Plasmatic immunoreactive insulin in trained athletes]V Karlícek, O Topolcan, J Jeschke
Casopis Lekaru Ceskych|June 16, 1978
[Contemporary state and perspectives of radioimmunological methods in nephrology (author's transl)]K Horký, K Opatrný, V Karlícek, et al.
Pageof 4